he release of dopamine in the brain causes the "high" or exaggerated sense of pleasure associated with drug abuse. CPP-109 works by indirectly lowering the level of dopamine in the brain. Specifically, GABA — gamma-aminobutyric acid — is a neurotransmitter in the brain that inhibits the release of dopamine. GABA, however, is broken down by GABA transaminase (GABA-T). CPP-109 works by inhibiting GABA-T and consequently increasing the level of GABA, which then lowers the level of dopamine and turns off the "high."
CPP-109 works without the apparent side effects typically associated with GABA agonists. Thus targeting brain GABAergic systems with drugs such as CPP-109 is a potentially effective treatment for cocaine, methamphetamine and other substance dependencies.
| Composite brain scans of six baboons showing effect of CPP-109 on cocaine use courtesy Brookhaven National Laboratory | ||
|---|---|---|
![]() | ![]() | ![]() |
| Baseline: dopamine levels normal | After cocaine: dopamine levels very high | After CPP-109 and cocaine: dopamine levels near normal |
Read a pilot study on vigabatrin and ocular safety.
See an animation of how CPP-109 works. (11.4 MB file, courtesy Brookhaven National Laboratory)